TERZI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 1.207
EU - Europa 1.081
AS - Asia 388
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.680
Nazione #
US - Stati Uniti d'America 1.187
CN - Cina 319
SE - Svezia 233
FI - Finlandia 213
IE - Irlanda 211
UA - Ucraina 188
DE - Germania 142
IT - Italia 36
GB - Regno Unito 33
SG - Singapore 28
TR - Turchia 22
CA - Canada 20
IN - India 15
BE - Belgio 12
NL - Olanda 5
BG - Bulgaria 4
EU - Europa 3
PK - Pakistan 3
FR - Francia 2
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
VE - Venezuela 1
Totale 2.680
Città #
Chandler 249
Jacksonville 221
Dublin 211
Dearborn 141
Ann Arbor 61
Beijing 61
Ashburn 57
Nanjing 56
Princeton 47
San Mateo 41
Bremen 31
Helsinki 28
Shanghai 28
Wilmington 27
New York 24
Izmir 21
Toronto 19
Kunming 18
Hefei 17
Shenyang 17
Boardman 15
Salerno 15
Des Moines 14
Hebei 14
Nanchang 14
Jiaxing 13
Pune 13
Singapore 13
Brussels 12
Düsseldorf 11
Jinan 10
Tianjin 10
Woodbridge 8
Borås 6
Rockville 6
Changsha 5
Grafing 5
Guangzhou 5
Zhengzhou 5
Fremont 4
Naples 4
Norwalk 4
Sofia 4
Auburn Hills 3
Hangzhou 3
Lahore 3
Taiyuan 3
Taizhou 3
Amsterdam 2
Chicago 2
Chongqing 2
Houston 2
Huizen 2
Mestre 2
Monmouth Junction 2
Ningbo 2
Palermo 2
Quzhou 2
Volta Mantovana 2
Wuhan 2
Ankara 1
Ardabil 1
Augusta 1
Baotou 1
Boston 1
Cervignano Del Friuli 1
Changchun 1
Chengdu 1
Dallas 1
Distrito Federal 1
Frankfurt am Main 1
Fuzhou 1
Huzhou 1
Lanzhou 1
Leawood 1
Lishui 1
Los Angeles 1
Luxembourg 1
Milan 1
Parma 1
Phoenix 1
Redmond 1
Seattle 1
Shenzhen 1
Southend 1
Stockholm 1
Wenzhou 1
Zagreb 1
Totale 1.652
Nome #
P-129 NUOVA ASSOCIAZIONE GENOTIPO/FENOTIPO IN UN CASO DI SINDROME SURRENO-GENITALE CLASSICA CON SEGNI TARDIVI DI VIRILIZZAZIONE. 102
influences of birth brain size on the ratio between newborn serum insulin-like growth factor binding protein-2-and -3 :role of birth size after controlling for the presence of intrauterine growth retardation and of preterm birth 95
Insulin sensitivity in obese children: which clinical and biochemical parameters are useful in clinical practice? 83
Insulin production and resistance in cystic fibrosis: Effect of age, disease activity, and genotype 82
Final height of Internationally adopted girls with treated and untreated precocious puberty. 78
DECREMENTS IN NEWBORN SERUM IGF-I / IGFBP-3 RATIO ASSOCIATED TO PARENTERAL GLUCOSE ARE NOT FULLY EXPLAINED BY HEMATOCRIT VARIABILITV 76
Modificazioni e rapporti di IGF-1, IL-6, TNF-alfa, adiponectina e resistina con markers di sensibilità insulinica nella fibrosi cistica 76
The balance between estimated birth brain weight and birth body weight as a predictor of the ratio between circulating levels of insulin-like growth factor binding protein-2 and -3 in newborns free of life-threatening disease:role of gestational age 74
New insights into glucose metabolism in cystic fibrosis (CF) 72
The percentage of birth body weight represented by estimated birth brain weight : predictor effects on circulating insulin-like growth factor (IGF)-1 and IGF-2, and on balance between circulating IGF-1 and IGF-2 in newborns free of life-threatening disease. 71
INFLUENCE OF BODY MASS INDEX VARIATIONS ON CORRESPONDING SYSTOLIC BLOOD PRESSURE TRENDS IN INSULIN-DEPENDENT DIABETES MELLITUS ADOLESCENTS APPROACHING FINAL HEIGHT: INITIAL SEARCH OF A ROLE FOR INSULIN DOSE 67
Catecholaminergic activity and adrenal-ovarian steroidogenesis in oligomenorrhea with or without IDDM 67
Gestational age and serum Insulin-Like Growth Factor-I appear related to the ratio between serum levels of Insulin-Like Growth Factor Binding Proteins 1 and 3 in newborns free of severe disease 67
Head circumference at birth as a predictor of relationship between circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding proteins 2 and 3 in newborns who are not life-threatened : role of caesarean section and of gestational age. 67
CALORIC INTAKE MODALITIES AND THE RATIO BETWEEN INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 2 AND 3 IN THE NON LIFE-THREATENED NEWBORN. 66
INSULIN DOSIS MAY NOT FULLY ACCOUNT FOR HBAIC RELATIONS WITH HEIGHT MEASURED AT A LONGTUDINAL GROWTH ARREST IN INSULIN - DEPENDENT DIABETES MELLITUS (IDDM) ADOLESCENTS 64
INFLUENCES OF GESTATIONAL AGE ON THE INSULIN-LIKE GROWTH FACTOR-I / INSULIN-LIKE GROWTH FACTOR-II RATIO MAY BE INDEPENDENT OF CAESAREAN SECTION AND OF OTHER BIRTH BODY WEIGHT-RELATED CONDITIONS IN NEWBORNS FREE OF SEVERE DISEASE 64
Predictor effects of head circumference at birth on serum insulin-like growth factor-1 and on serum insulin-like growth factor-.1 relation to serum insulin-like growth factro-2 in the human newborn free of life-threatening disease : Relevance of gestational age beyond caesarean section 63
Blood pressure monitoring in children undergoing food challenge: association with anaphylaxis 61
Evidences of ovarian hyperfunction in adolescent girls with insulin-dependent diabetes mellitus (IDDM) and menstrual disorders 59
The ratio between serum Insulin-Like Growth Factor Binding Proteins 2 and 3 could be steadily related to gestational age and to serum Insulin-Like Growth Factor-I in newborns without severe disease 59
SERUM IGF-I - DEPRESSING FACTORS MAY BE ASSOCIATED TO PARENTERALLY DELIVERED GLUCOSE IN NEWBORNS FREE FROM LIFE - THREATENING DISEASE 57
CORRELATIONS OF MEAN GLYCATED HEMOGLOBIN WITH HEIGHT AND BODY MASS INDEX RECORDED CLOSE TO FINAL HEIGHT IN INSULIN-DEPENDENT DIABETES MELLITUS ADOLESCENTS: RELEVANCE OF HEIGHT AND BODY MASS INDEX RECORDED AT THE BEGINNING OF THE CHOSEN GLYCATED HEMOGLOBIN OBSERVATION PERIOD 57
R. Virdis, M.E. Street, C. Terzi, D.W. Lusolo, G. Tenaglia 55
GESTATIONAL AGE AND INSULIN-LIKE GROWTH FACTOR-I APPEAR RELATED TO THE RATIO BETWEEN SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 AND 3 IN NEWBORNS FREE OF SEVERE DISEASE. 54
PARENTERAL GLUCOSE INFUSIONS MAY INTERACT WITH HEMATOCRIT IN DEPRESSING THE SERUM INSULIN-LIKE GROWTH FACTOR-I / INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 RATIO IN CLINICALLY STABLE NEWBORNS 53
FACTORS RELATED TO PARENTERAL GLUCOSE INFUSIONS MAY INTERACT WITH HEMATOCRIT IN DEPRESSING SERUM INSULIN-LIKE GROWTH FACTOR-I MEASURED IN CLINICALLY STABLE NEWBORNS SHORT AFTER BIRTH 53
POSTNATAL BODY WEIGHT CHANGE AS A CANDIDATE PREDICTOR OF SERUM IGF-I IN NEWBORNS FREE FROM SEVERE DISEASE 52
FACTORS RELATED TO BOTH PARENTERAL DEXTROSE INFUSIONS AND TO GESTATIONAL AGE MAY DEPRESS INSULIN-LIKE GROWTH FACTOR-I SERUM LEVELS AND THE SERUM INSULIN-LIKE GROWTH FACTOR-I / SERUM INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 RATIO IN CLINICALLY STABLE NEWBORNS 51
FACTORS OTHER THAN STATURAL GROWTH RATES MEDIATE SEX RELATIONS WITH RELATIVE CORPULENCE LEVELS IN DIABETES MELLITUS ADOLESCENTS CLOSE TO A STATURAL GROWTH ARREST 50
RELATIONSHIPS OF ORAL-ENTERAL AND OF PARENTERAL CALORIC INTAKE WITH THE RATIO BETWEEN INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-II IN NEWBORNS FREE OF LIFE-THREATENING DISEASE. 50
Precocious Puberty in Indian girls adopted in Italy 49
Prediction of serum Insulin-like Growth Factor (IGF)-Iratio by brain /birthweight ratio in newborns free of life-threatening disease:relevance of Caesarean section 49
THE RATIO BETWEEN SERUM INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 2 AND 3 COULD BE STEADILY RELATED TO GESTATIONAL AGE AND AND TO SERUM INSULIN-LIKE GROWTH FACTOR-I IN NEWBORNS WITHOUT SEVERE DISEASE. 48
RELATIONS OF BODY MASS INDEX VARIATIONS TO CHRONOLOGICALLY CORRESPONDING SYSTOLIC AND DIASTOLIC BLOOD PRESSURE TRENDS IN INSULIN-DEPENDENT DIABETES MELLITUS ADOLESCENTS: RELEVANCE OF INTERINDIVIDUAL HEIGHT DIFFERENCES DURING THE LAST PART OF STATURAL GROWTH 47
LUTEINIZING HORMONE RESPONSES TO LEUPROLIDE ACETATE DISCRIMINATE BETWEEN HYPOGONADISM AND CONSTITUTIONAL DELAY OF PUBERTY 46
SEX RELATIONS TO RELATIVE CORPULENCE LEVELS ARE NOT FULLY EXPLAINED BY GLYCAEMIC CONTROL AND INSULIN DOSE IN INSULIN-DEPENDENT DIABETES MELLITUS ADOLESCENTS CLOSE TO FINAL HEIGHT 42
RELATIONS OF BODY MASS INDEX VARIATIONS TO CHRONOLOGICALLY CORRESPONDING SYSTOLIC AND DIASTOLIC BLOOD PRESSURE TRENDS DURING 4 YEARS PRECEDING A STATURAL GROWTH ARREST IN INSULIN-DEPENDENT DIABETES MELLITUS ADOLESCENTS 42
Neurofibromatosis type 1 and precocious puberty 42
CROSS-VERIFICATION OF PEDIATRICIANS-MOTHERS KNOWLEDGE OF NUTRITIONAL RICKETS. 42
PARENTERAL GLUCOSE INFUSIONS MAY BE ASSOCIATED TO DEPRESSORS OF THE RATIO BETWEEN SERUM IGF-I AND SERUM IGFBP3 IN NEWBORNS FREE FROM LIFE-THREATENING DISEASE 39
Delayed and not precocious puberty is the most frequent pubertal disorder in neurofibromatosis 1 (NF1) 38
Management of insulin dependent diabetes mellitus in adolescents 38
SERUM IGF-I DECREMENTS ASSOCIATED TO INTRAVENOUS GLUCOSE IN NEWBORNS ARE NOT FULLY EXPLAINED BY HEMATOCRIT VARIABILITY 37
Precocious anticipated puberty in international adopted girls: to treat or not to treat? 34
Relation of brain/ birthweight ratio to the ratio between serum Insulin-like Growth Factor Binding Protein-2 and -3 in newborns free of life-threatening disease: role of Caesarean section 33
Ovarian 17α-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic 14
Totale 2.685
Categoria #
all - tutte 8.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/2020673 109 85 45 10 72 99 98 10 63 28 6 48
2020/2021285 2 45 34 1 48 0 42 3 51 3 56 0
2021/2022209 4 1 0 18 7 6 21 40 9 17 20 66
2022/2023914 108 79 79 56 94 109 5 81 270 4 26 3
2023/2024231 14 26 2 6 17 77 23 20 15 8 17 6
Totale 2.685